Ethyl 2-(2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamido)acetate

Catalog No. :
ACSOJJ805
CAS No. :
578754-67-3
Molecular Formula :
C19H18BrN5O3S
Molecular Weight :
476.36

IUPAC Name:ethyl (2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetyl)glycinate

Ethyl 2-(2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamido)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamido)acetate
IUPAC Nameethyl (2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetyl)glycinate
Molecular FormulaC19H18BrN5O3S
Molecular Weight476.36
SMILESO=C(OCC)CNC(CSC1=NN=C(C2=CC=CN=C2)N1C3=CC=C(Br)C=C3)=O
InChI KeyIXGGXDHRRLBGLY-UHFFFAOYSA-N
SynonymET((((4-(4-BR-PH)-5-(3-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)AC)AMINO)ACETATE;SALOR-INT L417459-1EA;ethyl 2-(2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamido)acetate;Glycine, N-[[[4-(4-bromophenyl)-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]acetyl]-, ethyl ester (9CI)
CAS No.578754-67-3

Synthetic Route by SureRoute

1. ACSOJJ805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSOJJ805 route product structure diagram
    ACSOJJ805578754-67-3
Inquiry

2. ACSOJJ805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSOJJ805 route product structure diagram
    ACSOJJ805578754-67-3
Inquiry

Comments (0)